1. Home
  2. TARS vs HMN Comparison

TARS vs HMN Comparison

Compare TARS & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • HMN
  • Stock Information
  • Founded
  • TARS 2016
  • HMN 1945
  • Country
  • TARS United States
  • HMN United States
  • Employees
  • TARS N/A
  • HMN N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • HMN Property-Casualty Insurers
  • Sector
  • TARS Health Care
  • HMN Finance
  • Exchange
  • TARS Nasdaq
  • HMN Nasdaq
  • Market Cap
  • TARS 1.8B
  • HMN 1.7B
  • IPO Year
  • TARS 2020
  • HMN 1991
  • Fundamental
  • Price
  • TARS $40.65
  • HMN $42.11
  • Analyst Decision
  • TARS Strong Buy
  • HMN Buy
  • Analyst Count
  • TARS 7
  • HMN 4
  • Target Price
  • TARS $67.14
  • HMN $46.00
  • AVG Volume (30 Days)
  • TARS 552.3K
  • HMN 271.2K
  • Earning Date
  • TARS 08-07-2025
  • HMN 08-06-2025
  • Dividend Yield
  • TARS N/A
  • HMN 3.32%
  • EPS Growth
  • TARS N/A
  • HMN 75.77
  • EPS
  • TARS N/A
  • HMN 2.76
  • Revenue
  • TARS $233,674,000.00
  • HMN $1,625,600,000.00
  • Revenue This Year
  • TARS $122.94
  • HMN $7.70
  • Revenue Next Year
  • TARS $44.14
  • HMN $5.70
  • P/E Ratio
  • TARS N/A
  • HMN $15.24
  • Revenue Growth
  • TARS 449.03
  • HMN 6.67
  • 52 Week Low
  • TARS $20.08
  • HMN $31.81
  • 52 Week High
  • TARS $57.28
  • HMN $44.44
  • Technical
  • Relative Strength Index (RSI)
  • TARS 40.26
  • HMN 44.53
  • Support Level
  • TARS $39.25
  • HMN $41.61
  • Resistance Level
  • TARS $42.01
  • HMN $43.17
  • Average True Range (ATR)
  • TARS 1.93
  • HMN 0.74
  • MACD
  • TARS -0.05
  • HMN -0.21
  • Stochastic Oscillator
  • TARS 22.95
  • HMN 20.33

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The company uses several former teachers in its salesforce. Its segments include Property and Casualty, Supplemental & Group Benefits, Life & Retirement, and Corporate and Other.

Share on Social Networks: